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1. SUMMARY 
The new ligands (E)-4-(((pyridine-2-ylmethyl)imino)methyl)aniline (L1) and (E)-2-(((5-
bromopyridin-2-yl)methylene)amino)phenol (L2OH) have been prepared by the condensation of 
4-aminobenzaldehyde and 2-pycolylamine or 5-bromopycolynaldehyde and 2-aminophenol 
respectively. The reaction of L1 with Na2PdCl4 produce a mixture of the compounds [PdCl2(L1)] 
and [PdCl2(2-pycolylamine)], this last one due to the ligand hydrolysis. The presence of a 
phenolic ring with a hydroxyl group susceptible to be deprotonated in ligand L2OH causes that 
the reaction of this ligand with Na2PdCl4 or [PtCl2(DMSO)2] produce a mixture of the compounds 
[MCl(L2O)] and [MCl2(L2OH)], {M = Pd(II), Pt(II)}. The ligand L2OH acts as a (N,N’,O) tridentate 
donor group in the former one compound or as a (N,N’) bidentate ligand in the second one. 
Modifying the pH it is possible to obtain pure compounds, but the [MCl2(L2OH)] complexes 
synthesized are very unstable in solution. 
The ligands and the metallic compounds were characterized by elemental analysis, infrared 
spectroscopy (IR) and mono- and two-dimensional NMR spectroscopies. It was also possible to 
determinate the crystalline structure of L2OH by X-ray diffraction.  
The interaction with DNA was studied for [MCl(L2O)] {M = Pd(II), Pt(II)} and [PtCl2(L2OH)] 
complexes by UV-Vis and fluorescence spectroscopies, circular dichroism and electrophoresis.  
The complexes that, in general, present more interaction with DNA are [PdCl(L2O) and 
[PtCl2(L2OH)]]. 
 
Keywords: Pd(II) and Pt(II) complexes, DNA interaction, Schiff bases. 
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2. RESUM 
Els nous lligands (E)-4-(((piridina-2-ilmetil)imino)metil)anilina (L1) i (E)-2-(((5-bromopiridina-
2-il)metilen)amino)fenol (L2OH) s’han preparat mitjançant la condensació de 4-
aminobenzaldehid i 2-picolilamina o 5-bromopicolilaldehid i 2-aminofenol respectivament. La 
reacció de L1 amb Na2PdCl4 produeix una barreja dels compostos [PdCl2(L1)] i [PdCl2(2-
picolilamina)], aquest últim a causa de la hidròlisi del lligand. La presència d’un anell fenòlic 
amb un grup hidroxil susceptible a ser desprotonat en el lligand L2OH fa que la reacció 
d’aquest lligand amb Na2PdCl4 o [PtCl2(DMSO)2] produeixi una barreja dels compostos 
[MCl(L2O)] i [MCl2(L2OH)], {M = Pd(II), Pt(II)}, on L2OH actua com a grup donador (N, N ', O) 
tridentat en el primer cas o com a lligand (N, N') bidentat en el segon. La modificació del pH fa 
possible obtenir els compostos purs, però els complexos [MCl2(L2OH)] són molt inestables en 
solució. 
Els lligands i els compostos metàl·lics es van caracteritzar per anàlisi elementals, 
espectroscòpia infraroja (IR) i RMN mono i bidimensional. També es va poder determinar 
l’estructura cristal·lina de L2OH mitjançant  difracció de raigs X. 
Es va estudiar la interacció amb l'ADN per als complexos [MCl(L2O)] {M = Pd(II), Pt(II)} i 
[PtCl2(L2OH)] per espectroscòpies UV-Vis i fluorescència, dicroisme circular i electroforesi. 
Els complexos que, en general, presenten més interacció amb l'ADN són [PdCl(L2O)] i 
[PtCl2(L2OH)]]. 
 
Paraules clau: Complexos de Pd(II) i Pt(II), interacció and l’ADN, bases de Schiff.  
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3. INTRODUCTION 
Cancer is a set of diseases in which the body produces an excess of malignant cells (known 
as cancerous), which growth beyond the normal limits that invade healthy tissues. These cells 
affect organs and tissues due to rapid expansion through lymphatic system or circulatory; this 
expansion is called metastasis1.  
Many cancers form solid tumors, which are an accumulation of cancerous cells but blood 
cancers, such as leukemia, generally do not form solid tumors. 
Nowadays there are some treatments to overcome it: radiotherapy which uses X-rays or γ-
rays, surgery to remove the tumor and chemotherapy which consist in the administration of 
several drugs to eliminate the cancerous cells. There are two types of drugs in chemotherapy: 
ones that inhibit DNA synthesis (like cisplatin) and others that act on cytoplasmic compounds 
that are necessary in cell division1. 
One of the most used anticancer drugs is cis-diamminedichloridoplatinum(II), cisplatin 
(Fig.1a), which antitumor properties were discovered by Barnett Rosenberg in 1960. It is 
routinely used for the treatment of testicular and ovarian cancer, and is increasingly used 
against others tumors, such as cervical, bladder and head/neck tumors2. However, its use is 
limited by the severe side effects that it presents like neurotoxicity and nephrotoxicity, its low 
solubility and the appearance of resistance, both acquired and intrinsic3.  
The primary cisplatin target is DNA. In the blood stream where the chloride concentration is 
relatively high (100 mM) the chloride ligands stay attached to the drug. When it reaches the 
tumor is thought that enters to the cell by passive diffusion or by active protein-mediated 
transport systems. Ones inside the cell, the lower chloride concentration (4-20 mM) in the 
cytoplasm produce a drug aquation with the loss of one or both of chloride ligands and can go 
on to bind to DNA4. Cisplatin will bind at the N7 position of two neighbouring guanine bases and 
to a lesser extent adenine, forming a wild range of adducts, particularly 1,2-GpG intrastrand 
adducts producing a kink of the DNA structure. This DNA distortion prevents replication and 
transcription, which ultimately leads to cellular apoptosis (cell death)2.  
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Of the thousands of complexes tested over the years in the quest for new platinum drugs 
that would perform better than cisplatin, very few have entered clinical trials: carboplatin and 
oxaliplatin (Fig. 1b and 1c respectively) were approved for clinical use worldwide, whereas 
nedaplatin, lobaplatin and heptaplatin (Fig. 1d, 1e, and 1f) were only approved for use in Japan, 
China and South Korea, respectively. Carboplatin is used for the same cancers that cisplatin but 
it has less toxicity so it can be used in higher doses and oxaliplatin is used for colorectal 
cancer3.  
 
 
 
 
     
 
 
 
 
Figure 1. a) Cisplatin, b) carboplatin, c) oxaliplatin, d) nedaplatin, e) lobaplatin, f) heptaplatin. 
 
Although these compounds undoubtedly present an improvement over cisplatin in terms of 
side-effects (carboplatin) and selectivity (oxaliplatin) they suffer from similar drawbacks, albeit in 
less extent. Attempts to overcome these shortcomings have results in different compounds: i) 
non-classical platinum complexes or another metallic complexes with different DNA-binding 
modes, ii) Pt-complexes that accumulate at the tumor site by a drug targeting and delivery 
strategy, iii) Pt-complexes that are activated only in tumor  tissues or cells (prodrugs)5. 
Consequently, the development of new drugs is still required.  
Because of the similarities between Pt(II) and Pd(II), some palladium complexes have been 
also studied. Some investigations show that Pd(II) compounds have better cytotoxicity, less 
nephrotoxicity and higher specificity than cisplatin and its analogues. In terms of usefulness, the 
slow dissociation pattern of platinum complexes compared to palladium (105 times faster) makes 
New metallic compounds with ligands derived from Hpyrimol. Study their interaction with DNA. 9 
 
them more applicable6. A recent trend observed in palladium-based anticancer drugs is to focus 
on the development of palladium (II) complexes with slower rates of hydrolysis choosing  
polidentate nitrogen ligands and suitable leaving groups7.  
The imines or Schiff bases form stable complexes with transition metals. They have been 
taken importance as a ligands due to their preparative accessibilities, varied denticities (forming 
a five-membered chelate ring), structural varieties, solubility in most of common solvents and 
thermal stability. They also have biomimetic properties because they can imitate structural 
characteristic of active sites7,8. In that context, a square-planar copper(II) complex with 
remarkable DNA-cleaving properties was obtained from a very simple Schiff-base ligand, 
namely 4-methyl-2-N-(2-pyridylmethylene)aminophenol (Hpyrimol)9. In addition, the use of 
Hpyrimol allowed the synthesis of efficient nuclease-active zinc(II) complexes, whose DNA-
cleaving activities were based on the ligand, through the generation of phenoxyl radicals10.Also 
the platinum compounds, [PtCl(Hpyrimol)] and [PtCl2(Hpyrimol)]) have been described together 
with their cytotoxic properties11,12. 
In order to develop new antitumor drugs which specifically target DNA, it is necessary to 
understand the different binding modes that a complex is capable to undertake. Basically, metal 
complexes interact with the DNA double helix in either a non-covalent or a covalent way. The 
non-covalent way includes three binding modes: intercalation between two adjacent base pair, 
major or minor grove binding and electrostatic interaction13. 
To see the interactions between DNA and complexes are used different techniques: UV-Vis 
and fluorescence spectrometry, circular dichroism and electrophoresis. These techniques allow 
having an idea to see the changes that the complexes produce to DNA.  
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4. OBJECTIVES 
In the present study, the aim is the preparation and characterisation of some metal 
complexes with Schiff-bases, inspired in Hpyrimol, as ligands, and study their interaction with 
DNA. 
The specific objectives are: 
- The synthesis and characterisation of new Schiff-base ligands. 
- The synthesis and characterisation of palladium (II) and platinum (II) complexes. 
- Study the interaction of the ligands and the complexes with DNA by UV-Vis and 
fluorescence spectroscopes, circular dichroism and electrophoresis. 
The ligands have been designed to be able to functionalize nanoparticles, so that 
subsequently, they can transport the drugs. Various types of nanoparticles (NPs), including 
inorganic ones (such as gold NPs), can be used as drugs carriers. 
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5. RESULTS AND DISCUSSION  
5.1. LIGANDS SYNTHESIS AND CHARACTERISATION  
The general method used to prepare a Schiff base or imine is a condensation between an 
aldehyde or a ketone and a primary amine (Fig. 2)14. 
 
        
Figure 2. General reaction of condensation. 
This reaction is an equilibrium so the product can be hydrolysed easily. The product could 
be in the E or Z form. The stability of the formed isomer depends on the sterical hindrance 
between the R groups. Generally, the most stable product is the E form for N-substituted imines 
so it will be considered that this is the isomer obtained.  
The condensation of 4-aminobenzaldehyde and 2-pycolylamine or 5-bromopycolynaldehyde 
and 2-aminophenol using ethanol as a solvent allows to obtain the ligands (E)-4-(((pyridine-2-
ylmethyl)imino)methyl)aniline (L1) or (E)-2-(((5-bromopyridin-2-yl)methylene)amino)phenol 
(L2OH), respectively, in good  yields (Fig. 3). 
 
 
 
Figure 3. a) (E)-4-(((pyridine-2-ylmethyl)imino)methyl)aniline (L1) and b) (E)-2-(((5-bromopyridin-2-
yl)methylene)amino)phenol (L2OH). 
The Schiff bases were characterized by elemental analysis, IR and mono- and two-
dimensional NMR spectroscopies (see Experimental section). The IR spectra of both ligands 
show the characteristic band at around 1600 cm-1 due to the ν(C=N) group. Furthermore, it can 
be seen the bands of the substituent groups (ν(N-H) at 3300 cm-1 for L1 and ν(O-H) at 3349 cm-
1 for L2OH). 
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One- and two-dimensional NMR experiments suggest that only one isomer (E-form) is 
present in solution. The common feature in the 1H-NMR spectra of Schiff bases is the imine 
proton signal which appears as a singlet in the range 8.0-9.0 ppm (δ= 8.2 ppm for L1 and δ= 8.7 
ppm for L2OH) and is indicative that the imine bond is formed. 
For the ligand L1 it can also be observed the signal corresponding to the amine group of the 
phenyl ring as a singlet at 5.6 ppm. This fact indicates that no condensation has occurred 
between molecules of 4-aminobenzaldehyde.  
Crystals of L2OH suitable for X-ray analyses could be obtained by diffusion of diethyl ether 
into a MeOH solution of the ligand. The molecular structure with the corresponding atom 
labelling is shown in Fig. 4 and crystallographic and refinement parameters are summarised in 
Appendix 3.  
The structure consists of discrete molecules which interact with two adjacent molecules by 
hydrogen bond. The distance between the oxygen (O1) and the hydrogen of a neighbouring 
molecule is 2.25 Å. 
The distance of C7-N1 bond [1.273(2) Å] is similar to other imines found in the literature15. 
This distance and the C8-C7-N1 bond angle [121.38(17) º] illustrate the double bond character 
and the sp2 hybridization of the imine carbon atom. The single bond N1-C6 has a longer 
distance [1.411(2) Å] than the imine C7-N1 bond.  
 
 
 
 
 
Figure 4. Representation of the molecular structure of L2OH with the corresponding atom labelling. The 
hydrogen atoms are omitted for clarity. Selected bond lengths are C7-N1 1.273(2) Å; C8-N2 1.345(2) Å 
and C7-N1 1.411(2) Å and angles C7-C8-N1 121.38(17) º and the dihedral angle between C6-N1-C7-C8 
179.8 º. 
The value of the torsion angle C8-C7-N1-C6 (179.8º) indicate that the imine adopts the anti-
(E) conformation16. 
The phenyl and pyridine rings are planar, and they are practically coplanar. 
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5.2. METAL COMPLEXES SYNTHESIS AND CHARACTERISATION 
The reaction in methanol of stoichiometric amounts of [PtCl2(DMSO)2] or Na2PdCl4, 
previously dissolved and filtered, and the ligand L2OH produces a mixture of two products: 
[MCl2(L2OH)] {where L2OH acts as a (N,N’) bidentate ligand} and [MCl(L2O)] {where L2OH acts 
as a tridentate (N,N’,O) donor group} {M= Pd(II), Pt(II)} (Fig. 5). 
 
 
 
Figure 5. Metallic complexes obtained {M = Pd(II); Pt(II)}. a) [MCl2(L2OH)], b) [MCl(L2O)]. 
In order to obtain the two pure compounds, the pH of the reaction was modified. Adding 
stoichiometric amounts of hydrochloric acid the complex [MCl2(L2OH)] should be obtained, 
while the addition of a base like triethylamine should lead to the complex [MCl(L2O)].  
All pure complexes have been characterized by the usual techniques of elemental analysis, 
IR and NMR spectroscopies. 
When the reaction is carried out under basic conditions only the expected product is 
obtained {[MCl(L2O)]} {M = Pd(II) or Pt(II)}. The 1H NMR spectra of both complexes are 
consistent with the proposed structures. The proton signals more shifter compared with those of 
the free ligand are the imine and the alpha proton of pyridine (H6) in agreement to the ligand 
coordination by the nitrogen of pyridine and imine. The signal of this last proton appears as a 
doublet due to the coupling with the proton H3 in trans. In these spectra it is also observed that 
the signal corresponding to the proton of the OH group disappears indicating that this group is 
coordinated.  
In the 1H NMR spectrum of [PtCl(L2O)] is possible to observe the 1H-195Pt coupling between 
the iminic proton and platinum. The value of the measured coupling constant is 3JH7-195Pt = 100 
Hz that is in good agreement with those observed for other Pt(II) complexes17. 
In IR spectra the ν(C=N) band is observed at 1576 cm-1 for [PdCl(L2O)] and at 1591 cm-1 for 
[PtCl(L2O)].  
When the reaction was carried out in acid conditions, for the platinum it was possible to 
obtain the expected product [PtCl2(L2OH)] pure. In the 1H NMR spectrum only one set of signals 
is observed that can be assigned to the compound. In this spectrum, a difference of the case of 
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the compound [PtCl(L2O)], there is a singlet at 10.1 ppm which belongs to the hydroxyl group 
and is indicative that the ligand is not bonded to the metal through the oxygen. The analytical 
results agree with the proposed structure. 
Although the pure [PtCl2(L2OH)] compound was obtained, this compound in solution is 
hydrolysed in 36h. 
The synthesis in acid conditions for the Pd(II) complex allows to obtain the pure solid 
product but in solution is quickly converted in [PdCl(L2O)]. In the 1H NMR spectrum is observed 
the signal of the hydroxyl group at 10.1 ppm and other signals that can be assigned to the 
[PdCl2(L2OH)] compound, but also there are signals that belong to [PdCl(L2O)] and to aldehyde 
and amine. In the IR spectra for both compounds appear the ν(O-H) about 3300 cm-1 and the 
ν(C=N) in 1600 cm-1. 
The relative situation of signals of the imine proton and the alpha proton of pyridine (H6) in 
the 1H NMR spectra allows the complexes [MCl2(L2OH)] and [MCl(L2O)] to be easily identified. 
In the [MCl(L2O)] complexes the iminic proton signal appears at lower fields than the alpha 
pyridine proton whereas in the [MCl2(L2OH)] complexes this order is inverted, the iminic proton 
signal appears at higher fields than the alpha pyridine proton. 
The reaction in methanol of stoichiometric amounts of Na2PdCl4, previously dissolved and 
filtered, and the ligand L1 produces a mixture of products, [PdCl2(L1)] and [PdCl2(2-
pycolylamie)]. This last product was obtained pure by crystallization of the filtrate. These 
products could be characterized by 1H NMR.  
The 1H NMR spectrum shows the characteristic signal of the imine proton (δ= 8.4 ppm) of 
[PdCl2(L1)] compound. Also is possible to assign some of the pycolylamine signals that belong 
to the [PdCl2(2-pycolylamine)] complex and the aldehyde (δ= 9.5 ppm) of 4-
aminobenzaldehyde. The presence of aldehyde indicates that the imine was hydrolysed and the 
resulting amine reacts with Na2PdCl4 to form [PdCl2(2-pycolylamine)]. 
5.3. DNA INTERACTIONS   
5.3.1. Fluorescence spectroscopy  
The ability of Pd(II) and Pt(II) complexes to displace the DNA-intercalator ethidium bromide 
(EB) was evaluated using fluorescence spectroscopy. EB fluoresces when it is intercalated 
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between DNA base pairs (λem = 592 nm). If the complexes are able to displace the EB, it is 
expected that the fluorescence decreases. To compare the displacement ability of the 
complexes, their quenching efficiency was assessed applying the Stern–Volmer equation (Eq. 
1)13. 
𝐼0
𝐼
= 1 + Ksv[complex] 
Equation 1. 
The corresponding Stern–Volmer quenching constant (Ksv), is determined by plotting I0/I 
versus [complex] (I0 and I being the emission intensities in the absence and the presence of the 
complex, respectively). 
The fluorescence spectra were recorded at constant concentrations of EB and DNA (of 
respectively, 75 and 15 μM in cacodylate-NaCl buffer) upon addition and incubation for 24h at 
37 °C of increasing amounts of the metal complex, namely in the 0–150 μM range. The 
emission intensities were measured from 530 to 700 nm with an excitation wavelength at 514 
nm. 
      
Figure 6. [PtCl(L2O)] Fluorescence spectra and I0/I versus [complex]. 
 
The fluorescence spectrum of [PtCl(L2O)] is shown in Fig. 6. When the complex 
concentration increases, the fluorescence does not decrease so the constant cannot be 
calculated because the plot of I0/I versus [complex] doesn’t follow a lineal tendency (Insert Fig. 
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6). The [PdCl(L2O)] and [PtCl2(L2OH)] complexes present similar behaviour (Appendix 8).That 
could be attributed to the no displacement of the EB by the complexes indicating they could 
interact through another modes of interaction, for instance groove binding. This means that EB 
has a bigger Ksv than the prepared complexes. 
5.3.2. Circular dichroism (CD) 
Circular dichroism (CD) is a sensitive technique to monitor the conformational changes in 
the DNA secondary structure upon interaction with the synthesized compounds. The CD 
spectrum of the DNA B form consists of a positive band at 275 nm due to base stacking and a 
negative band al 245 nm due to helicity18. This is the most common form of DNA even though 
exist A and C forms that show a different spectra19.  
CD spectra of DNA after the addition of compounds L2OH, [PdCl(L2O)] and [PtCl(L2O)] 
incubated for 24 hours al 37ºC were recorded. The effect of these compounds on the secondary 
structure of DNA was studied by keeping the concentration of DNA at 100 μM varying the 
compounds concentration (0-200 μM) in a cacodylate-NaCl buffer. 
The obtained spectra are shown in Fig. 7. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. CD spectra of a) L2OH, b) [PdCl(L2O)] and c ) [PtCl(L2O)] 
a) b) 
c) 
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The maximums and the minimums of ellipticity (θ) at different ratio [metal]/[DNA] and the 
wavelengths at which they appear are shown in Table 1.  
 
Compund [metal]/[DNA] Θmax [a] λmax [nm] Θmin [a] λmin [nm] Δ Θmax Δ Θmin 
DNA - 6.6 273 -8.0 244 - - 
L2 0.2 7.0 273 -8.0 244 0.39 0.09 
 0.6 7.0 273 -7.7 245 0.31 0.25 
 1 7.3 272 -8.1 244 0.72 0.11 
DNA - 6.3 273 -8.4 243 - - 
[Pd(L2O)] 0.2 8.6 281 -6.8 245 2.24 1.61 
 0.6 13.7 288 -6.4 247 7.36 2.05 
 1.0 31.7 292 -6.0 253 25.38 2.46 
 2.0 36.4 292 -4.0 253 30.12 4.51 
DNA - 6.0 274 -5.7 242 - - 
[Pt(L2O)] 0.2 5.9 276 -5.4 242 0.12 0.26 
 0.6 6.4 276 -5.1 241 0.45 0.68 
 1.0 6.7 276 -5.2 240 0.72 0.54 
 2.0 7.0 275 -4.1 240 1.00 1.64 
a = (degrees · cm2 · dmol-1) x 103 
Table 1. Maximums and minimums of ellipticity (θ) at different ratio [metal]/[DNA] and their 
corresponding wavelengths. 
 
The ligand L2OH do not modify significantly the ellipticity of the bands neither the maximum 
nor minimum of wavelengths (Fig. 7a), Table 1), consequently the secondary structure of DNA 
is not modified. 
[PdCl(L2O)] complex (Fig. 7b)) has a big effect in DNA secondary structure, when complex 
concentration increases the positive ellipticity also improves while the negative band decreases 
(Table. 1). This change suggests that this complex can modify DNA B form to A form. CD 
spectra show also a displacement in the wavelength to higher values, when the complex 
concentration increases. This is called bathochromic effect20.  
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The modification of the ellipticity of DNA with increasing concentrations of [PtCl(L2O)] (Fig. 
7c), Table. 1) indicates only a slightly distortion of its secondary structure.  
5.3.3. Gel electrophoresis 
The DNA-cleaving properties of the complexes where investigated for pBR322 plasmid DNA 
(15 µM in base pairs) and different concentrations of the compounds (0-100 µM) in cacodylate-
NaCl buffer incubated at 37ºC for 24 hours. A loading buffer of xylene cyanol (4 µL) was added 
and the mixture was subjected to electrophoresis gel of agarose in TBE buffer (Tris-borate-
EDTA) at 100V for 1 hour. After, the gel was placed in a container with 150 mL of TBE and 15 
µL of display buffer (SYBR Safe) and was agitated overnight. 
Electrophoresis in agarose gel is one of the most used methods to separate and identify 
DNA fragments. Pure plasmid DNA gives two bands (lanes 6, 13, 20, 27), the most intense one 
corresponding to supercoiled DNA (form I), while the second one is ascribed to the circular 
nicked form (form II). There is another form which is linear (form III) and migrates between form 
I and II17.  
The agarose gel electrophoresis of L2OH, [PdCl(L2O)], [PtCl(L2O)] and [PtCl2(L2OH)] are 
shown in Fig. 8 respectively. The compounds concentrations are 5, 10, 25, 50 and 100 µM. 
 
 
 
 
 
 
 
 
 
Figure 8. Agarose gel electrophoresis images of pBR322 plasmid DNA incubated for 24 h at 37ºC in 
cacodylate-NaCl buffer with increasing concentration of compounds. Lane 1-5 L2OH (5-100 µM); lane 6, 
13, 20, 27 DNA control; lane 7, 14, 21, 28 cisplatin (10 µM); lane 8-12 [PdCl(L2O)] (5-100 µM); lane 15-
19 [PtCl(L2O)] (5-100 µM); lane 22-26 [PtCl2(L2OH)] (5-100 µM). 
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Incubation of DNA with cisplatin affects the electrophoretic mobility of both form I and form 
II; cisplatin-mediated unwinding of form I causes a diminution of its mobility, whereas the 
unwinding of form II increases its mobility because of a shortening effect on the DNA contour 
length (see lanes 7, 14, 21 and 28). Free ligand L2OH (Fig. 8 Lane 1-5) does not affect the 
structure of the DNA molecule.  
The gel electrophoresis results for [PdCl(L2O)] are shown in (Fig. 8 Lane 8-12). For 
[complex] > 10 µM complex seems to induce the unwinding of form I, converting it into form II. 
This may be explained by single-strand cleavage of the plasmid upon platinum binding. 
For [PtCl(L2O)] (Fig. 8 Lane 15-19), the electrophoresis images shown that the form II  is 
the predominant in low concentrations and for [complex] > 50 µM it is seen that DNA is almost 
broken.  
The electrophoresis of [PtCl2(L2OH)] (Fig. 8 Lane 22-26) show that in lower concentrations 
DNA do not change the DNA form, in a concentration of 10 µM DNA is in form II and increasing 
the concentrations until 100 µM DNA changes to form III.  
5.3.4. UV-Vis spectroscopy  
The interaction of the ligand L2OH and the complexes [MCl(L2O)] and [PtCl2(L2OH)] with 
DNA was investigated by UV-Vis spectrophotometric titration. Experiments were carried out by 
addition of increasing amounts of DNA (from 0 to 100 µM, in base pairs) to a 25 µM solution of 
the compounds in a cacodylate-NaCl buffer. All samples were incubated for 24 hours at 37ºC. 
The spectra were recorded from 200 to 800 nm.  
To compare the DNA-binding strength of the different compounds, their intrinsic binding 
constant Kb was calculated using Eq. 2.  
[DNA]
εa − εf
=
[DNA]
ε0 − εf
+
1
Kb(ε0 − εf)
 
Equation 2. 
Where εa is the extinction coefficient of the formed DNA-complex (Absobs/[complex]), εf is the 
extinction coefficient of the free complex in solution and ε0 is the extinction coefficient for the 
compound in the fully DNA-bound form. The intrinsic binding constant Kb were determined from 
the corresponding plots of [DNA]/( εa - εf) versus [DNA]. 
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The UV-Vis spectrum of [PdCl(L2O)] and its [DNA]/( εa - εf) versus [DNA] plot are shown in 
Fig. 9. The rest of the spectres are in the Appendix 9. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. [PdCl(L2O)] UV-Vis spectra and [DNA]/( εa - εf) vs [DNA]. 
The binding constant (Kb) of the compounds are shown in Table 2. 
 
Compound L2OH [PdCl(L2O)] [PtCl(L2O)] [PtCl2(L2OH)] 
Kb 8.5·104 1.3·106 1.6·105 3.8·106 
Table 2. Compounds Kb. 
 
The complexes that present a major interaction with DNA are [PdCl(L2O)] and 
[PtCl2(L2OH)], also [PtCl(L2O)] interacts with DNA but with a lower Kb. The ligand interacts with 
DNA but as it was expected it has the lowest Kb18. 
 
New metallic compounds with ligands derived from Hpyrimol. Study their interaction with DNA. 21 
 
 
6. EXPERIMENTAL SECTION 
Elemental analysis (C, H and N) were made in Serveis Cientifico-Tècnics de la Universitat 
de Barcelona. NMR experiments (proton, carbon and two-dimensional {1H-13C}-HQSC-NMR) 
were been done with Mercury 400MHz spectrometer. Infrared spectra were obtained using FT-
IR Thermo Nicolet 330, in a 4000-400 cm-1. UV-Vis experiments were performed with a Varian 
Cary-100 spectrophotometer. Fluorescence measurements were made with Nanolog-Horiba 
Jobin Yvon. Circular dichroism titrations were made with an A JASCO J-815 circular dichroism 
spectropolarimeter. The X-rays diffraction were collected on a Bruker APEX II QUAZAR 
diffractometer equipped with a microfocus multilayer monochromator with MoKα radiation (λ = 
0.71073 Å). Electrophoresis images were acquired using a Gel Doc EZ Imager instrument.  
6.1. MATERIALS AND METHODS 
Na2PdCl4 and [PtCl2(DMSO)2] were been prepared following literature processes 21, 22. The 
rest of reagents and solvents were obtained commercially (Arcos Organics and Sigma Aldrich) 
and were used without further purification.  
6.2. PREPARATION OF LIGANDS  
6.2.1. Preparation of (E)-4-(((pyridine-2-ylmethyl)imino)methyl)aniline (L1) 
An ethanolic solution (10mL) of 125mg (1.03 mmol) of 4-aminobenzaldehyde was added to 
a solution of 112mg (1.03 mmol) of 2-picolylamine in ethanol (10mL). The resulting solution was 
refluxed for 7 hours. After this time, it was filtered and concentrated to dryness on a rotator 
evaporator.  
 
 
Orange solid. Yield: 183mg [84%]. Analysis calculated for 
C13H13N3·0.4EtOH(%): C 72.16, H 6.77, N 18.29; found: C 70.2, H 6.7, N 
18.3.  IR (KBr cm-1): 3329 (ν(NH)), 1600 (ν(C=N)). 1H NMR (DMSO, 400 
MHz, ppm): δ 8.48 (dd, J= 4.0 Hz, 1H, H2), 8.23 (s, 1H, H9), 7.73 (td, J= 8.0 
Hz, 1H, H4), 7.43 (d, J= 8.0 Hz, 2H, H11, H16), 7.34 (d, J= 8.0 Hz, 1H, H5), 
7.22 (td, J= 4.0 Hz, 1H, H3), 6.55 (d, J= 8.0 Hz, 2H, H12, H15), 5.6 (s, 2H, 
H14), 4.71 (s, 2H, H7). 13C NMR (DMSO, 101 MHz, ppm): δ 162.9 (C9), 160.2 
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(C6), 152.0 (C13), 149.3 (C2), 137.1 (C4), 130.1 (C11, C16), 124.3 (C10), 122.6 
(C5), 122.4 (C3), 113.7 (C12, C15), 66.3 (C7). 
6.2.2 Preparation of (E)-2-(((5-bromopyridin-2-yl)methylene)amino)phenol) (L2OH) 
An ethanolic solution (10mL) of 125mg (0.68 mmol) of 5-bromopicolinaldehyde was added 
to a solution of 73mg (0.68 mmol) of 2-aminophenol. The resulting solution was refluxed for 2 
hours and concentrated to dryness on a rotator evaporator. 
 
 
Orange solid. Yield: 342mg [92%]. Analysis calculated for C12H9BrN2O(%): C 
52.01, H 3.27, N 10.11; found: C 51.8, H 2.9, N 10.1.  IR (KBr cm-1): 3349 
(ν(O-H)), 1585 (ν(C=N)). 1H NMR (DMSO, 400 MHz, ppm): δ 9.32 (s, 1H, 
H15), 8.86 (d, J=2.0 Hz, 1H, H6), 8.73 (s, 1H, H7), 8.39 (d, J= 8.0 Hz, 1H, H4), 
8.25 (dd, J= 2.0, 8.0 Hz, 1H, H3), 7.35 (d, J= 4.0, 8.0 Hz, 1H, H13), 7.17 (t, J 
=4.0, 8.0  Hz, 1H, H12), 6.95 (d, J= 4.0, 8.0 Hz, 1H, H10), 6.88 (t, J= 4.0, 8.0 
Hz, 1H, H11). 13C NMR (DMSO, 101 MHz, ppm): δ 158.3 (C7), 153. 7 (C14), 
152.1 (C6), 150.6 (C2), 140.0 (C4), 136.7 (C9), 129.1 (C12), 123.6 (C5), 122.5 
(C3), 120.1 (C13), 120.0 (C11), 116.8 (C10). 
6.3. PREPARATION OF COMPLEXES   
6.3.1. Synthesis of [PdCl(L2O)] 
A methanolic solution (10mL) of L2OH (100mg, 0.360 mmol) was added drop by drop to a 
methanolic solution of Na2PdCl2 (106mg, 0.360 mmol) which was filtered previously. The 
solution was stirred for 1 hour and the stoichiometric amount of NEt3 was added. After 1 hour of 
stirring the resulting precipitate was isolated.  
 
 
Purple solid. Yield: 112mg [75%]. Analysis calculated for 
[PdCl(C12H8BrN2O)]·0.5CH3OH·H2O(%): C 33.21, H 2.65, N 6.20; found: C 
33.0, H 2.4, N 6.3.  IR (KBr cm-1): 1576 (ν(C=N)). 1H NMR (DMSO, 400 MHz, 
ppm): δ 8.45 (dd, J= 8.0, 2.0 Hz, 1H, H3), 8.43 (s, 1H, H7), 8.32 (d, J= 2.0 Hz, 
1H, H6), 7.70 (d, J= 8.0 Hz, 1H, H4), 7.38 (d, J= 8.0 Hz, 1H, H13), 7.07 (t, J= 
8.0 Hz, 1H, H12), 6.49 (m, 2H, H10, H11). 13C NMR (DMSO, 101 MHz, ppm): δ 
175.7 (C7), 159.6 (C6), 151.1 (C2), 150.7 (C14), 143.7 (C4), 135.1 (C9), 134.2 
(C12), 128.1 (C3), 121.9 (C10), 119.6 (C11), 118.6 (C5), 115.7 (C13). 
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6.3.2. Synthesis of [PdCl2(L2OH)] 
The stoichiometric amount of HCl is added to a methanolic solution (10mL) of Na2PdCl2 
(106mg, 0.360 mmol) filtered previously. This solution is added drop by drop to a methanolic 
solution (10mL) of L2OH (100mg, 0.360 mmol). The resulting solution is stirred for 1 hour and 
filtered.  
 
Orange solid. Yield: 78mg [48%]. Analysis calculated for 
[PdCl2(C12H9BrN2O)](%): C 31.72, H 2.0, N 6.16; found: C 31.3, H 2.2, N 5.9. 
IR (KBr cm-1): 3274 (ν(O-H)), 1593 (ν(C=N)). 1H NMR (DMSO, 400 MHz, 
ppm): δ 10.12 (s, 1H, H15), 9.03 (d, J= 4.0 Hz, 1H, H6), 8.69 (dd, J= 4.0, 8.0 
Hz, 1H, H3), 8.69 (s, 1H, H7), 8.12 (d, J= 8.0 Hz, 1H, H4), 7.17 (m, 2H, H10, 
H12), 6.90 (d, J= 8.0 Hz, 1H, H13), 6.82 (t, J= 8.0 Hz, 1H, H11).  
6.3.3. Synthesis of [PtCl(L2O)] 
A methanolic solution (10mL) of L2OH (70mg, 0.253 mmol) was added to a solution of cis-
[PtCl2(DMSO)2] (107mg, 0.253 mmol, in 20mL of methanol), which was previously refluxed and 
filtered. The resulting solution was stirred for 30 minutes and the stoichiometric amount of NEt3 
was added. After 1 hour the resulting precipitate was isolate.   
 
 
Green solid. Yield: 57mg [45%]. Analysis calculated for 
[PtCl(C12H8BrN2O)]·0.5H2O(%): C 27.95, H 1.79, N 5.43; found: C 27.8, H 
1.6, N 5.3.  IR (KBr cm-1): 1591 (ν(C=N)). 1H NMR (DMSO, 400 MHz, ppm): 
δ 8.83 (s, 3JH-Pt= 100.0 Hz, 1H, H7), 8.53 (d, 1H, H6), 8.44 (dd, J= 8.0 Hz, 1H, 
H3), 7.62 (d, J= 8.0 Hz, 1H, H4), 7.40 (d, J= 8.0 Hz, 1H, H10), 7.05 (t, J= 8.0 
Hz, 1H, H12), 6.62 (d, J= 12 Hz, 1H, H13), 6.52 (t, J= 12.0 Hz, H11). 13C NMR 
(DMSO, 101 MHz, ppm): δ 178.1 (C2), 161.4 (C14), 153.1 (C7), 150.3 (C6), 
143.5 (C3), 135.4 (C9), 135.0 (C12), 128.8 (C4), 123.3 (C5), 119.2 (C10), 118.6 
(C13), 115.7 (C11). 
6.3.4. Synthesis of [PtCl2(L2OH)] 
The stoichiometric amount of HCl was added to a methanolic solution (20mL) of cis-
[PtCl2(DMSO)2] (30mg, 0.307 mmol) which was refluxed and filtered previously. This solution 
was added drop by drop to a solution of L2OH (85mg, 0.307 mmol) in 10mL of methanol, then 
the solution was stirred for 2 hours. The resulting solution is allowed to crystallize at room 
temperature.  
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Crystalline black solid. Yield: 45mg [27%]. Analysis calculated for 
[PtCl2(C12H9BrN2O)]·0.5H2O(%): C 26.54, H 1.67, N 5.16; found: C 26.6, H 
1.8, N 5.0.  IR (KBr cm-1): 3311 (ν(O-H)), 1651 (ν(C=N)). 1H NMR (DMSO, 
400 MHz, ppm): δ 10.15 (s, 1H, H15), 9.51 (d, J= 1.6 Hz, 1H, H6), 9.30 (s, 1H, 
H7), 8.76 (dd, J= 1.6, 8.0 Hz, 1H, H3), 8.17 (d, J= 8.0 Hz, 1H, H4), 7.21 (m, 
2H, H10, H12), 6.97 (d, J= 12.0 Hz, 1H, H13), 6.88 (t, J= 8.0 Hz, 1H, H11). 13C 
NMR (DMSO, 101 MHz, ppm): δ 173.4 (C7), 155.9 (C2), 151.2 (C14), 149.8 
(C6), 143.2 (C3), 141.5 (C9), 130.4 (C4), 130.1 (C12), 126.1 (C10), 120.1 (C5), 
118.1 (C11), 116.3 (C13). 
 
6.3.5. Synthesis of [PdCl2(L1)] 
A methanolic solution (10mL) of L1 (60mg, 0.284 mmol) was added drop by drop to a solution of 
Na2PdCl2 (84mg, 0.248 mmol) which was filtered previously. The solution was stirred for 30 
minutes and the resulting precipitate was isolated.  
 
 
Orange solid.  
[PdCl2(L1)] 1H NMR (DMSO, 400 MHz, ppm): δ 8.90 (d, J= 8.0 Hz, 1H, H2), 
8.40 (s, 1H, H9), 8.10 (t, 1H, H4), 7.71 (d, J=  8.0 Hz, 2H, H11, H16), 7.53 (m, 
2H, H3, H5), 6.69 (m, J= 8.0 Hz, 2H, H12, H15), 5.60 (s, 2H, H14), 5.54 (s, 1H, 
H7).  
 
[Pd(2-plycolylamine)] 1H NMR (DMSO, 400 MHz, ppm): δ 8.76 (d, J= 8.0 
Hz, 1H, H2), 8.05 (t, J= 8 Hz, 1H, H4), 7.62 (d, J= 8.0 Hz, 1H, H3), 7.51 (t, J=  
8.0 Hz, H5), 5.62 (s, 1H, H8). 
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7. CONCLUSIONS 
Two new Schiff bases [(E)-4-(((pyridine-2-ylmethyl)imino)methyl)aniline (L1) and (E)-2-(((5-
bromopyridin-2-yl)methylene)amino)phenol (L2OH)] were synthesized and characterized. The 
reaction of L2OH with Na2PdCl4 and [PtCl2(DMSO)2] allows to obtain pure palladium (II) and 
platinum (II) complexes [MCl(L2O)] and  [MCl2(L2OH)] optimizing the reaction’s pH. The 
characterization data of these compounds agree with the proposed structures. 
Fluorescence studies indicate that any of the complexes prepared cannot displace ethidium 
bromide (EB) so the Stern–Volmer quenching constant (Ksv) between EB and DNA is bigger 
than the synthesised complexes and DNA. 
Circular dichroism spectra show that the ligand L2OH does not change the secondary 
structure of DNA whereas the [MCl(L2O)] complexes do it. The palladium complex, [PdCl(L2O)], 
causes the biggest  modification. 
All the metallic complexes studied modify the mobility of the DNA as can be seen in the 
electrophoresis studies and some of they can even break it at high concentrations.  
UV-Vis studies show that the complexes that have more interaction with DNA are 
[PdCl(L2O)] and [PtCl2(L2OH)] and as it was expected the ligand has less interaction than the 
complexes.  
In general, all the studies carried out indicate that the complexes which have major 
interaction with DNA are [PdCl(L2O)] and [PtCl2(L2OH)] even thought more studies must be 
done.  
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9. ACRONYMS 
CD – Circular dichroism  
d – doublet 
dd – doublet of doublets  
DMSO – Dimethyl sulfoxide  
DNA – Deoxyribonucleic Acid 
HSQC – heteronuclear single quantum correlation  
IR – Infrared Spectroscopy 
m – multiplet 
NMR – Nuclear Magnetic Resonance 
Pd – palladium  
Pt – platimun 
s – singlet  
t – triplet 
TBE – Tris-borate-EDTA 
 UV-Vis – Ultraviolet-visible  
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APPENDIX 1: SPECTRA OF L1 
1H NMR (DMSO) 
 
 
 
 
 
 
 
 
13C NMR (DMSO) 
 
 
 
 
 
 
 
 
HSQC-NMR 
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IR (KBr) 
 
 
 
 
 
 
 
APPENDIX 2: SPECTRA OF L2OH 
1H NMR (DMSO) 
 
 
 
 
 
 
 
 
13C NMR (DMSO) 
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HSQC-NMR 
 
 
 
 
 
 
 
IR (KBr) 
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APPENDIX 3: CRYSTALLOGRAPHIC PARAMETERS OF 
L2OH 
   
Compound L2OH 
Empirical formula C12H9BrN2O 
Molecular weight (g·mol-1) 277.11 
Temperature (K) 100(2) 
Crystalline system monoclinic 
Cristal size (mm3) 0.30x0.23x0.20 
Space group P 21/n 
a (Å) 12.1970 
b (Å) 4.6219 
c (Å) 19.0106 
α (º) 90 
β (Å) 98.993 
γ (Å) 90 
Volume ( Å3) 1058.52(14) 
Z 4 
Pcalc (Mg/m3) 1.739 
µ (mm-1) 3.86 
F (000) 552.0 
Ө for data collection (º) 3.43-27.40 
Reflections collected / unique 2318 
Complements to theta 25.242 
Data / restrints / parameters 2318/0/149 
Goodness-of-fit on F2 1.079 
Final R indices [I>2σ(I)] R1 = 0.0237, 
wR2 = 0.0571 
R indices (all data)  R1 = 0.0281, 
wR2 = 0.0584 
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APPENDIX 4: SPECTRA OF [PDCL(L2O)] 
1H NMR (DMSO) 
 
 
 
 
 
 
 
 
 
 
 
 
13C NMR (DMSO) 
 
 
 
 
 
 
 
 
 
 
 
 
 
HSQC-NMR 
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IR (KBr) 
 
 
 
 
 
 
 
APPENDIX 5: SPECTRA OF [PTCL(L2O)] 
1H NMR (DMSO) 
 
 
 
 
 
 
 
 
 
 
 
 
 
13C NMR (DMSO) 
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HSQC-NMR  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IR (KBr) 
 
 
 
 
 
 
 
APPENDIX 6: SPECTRA OF [PDCL2(L2OH)] 
1H NMR (DMSO) 
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IR (KBr) 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX 7: SPECTRA OF [PTCL2(L2OH)] 
1H NMR (DMSO) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
13C NMR (DMSO) 
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IR (KBr) 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX 8: FLUORESCENCE SPECTRA 
[PdCl(L2O)] 
 
 
 
 
 
 
 
 
 
 
 
 
[PtCl2(L2OH)] 
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APPENDIX 9: UV-VIS SPECTRA 
L2OH 
 
 
 
 
 
 
 
 
 
 
 
 
 
[PdCl(L2O)] 
 
 
 
 
 
 
 
 
 
 
 
 
 
[PtCl2(L2OH)] 
  
  
 
